Julio Chavez is an Senior Associate Consultant in The Divisiopn of Hematology/Oncology at Mayo Clinic in Jacksonville, FL where he is the lymphomalead . He focus his clinical care and research in the treatment of various types lymphomas, particularly aggressive B-cell lymphomas. He is currently principal investigator in several trials with targeted therapies, immunotherapies and CAR-T cell therapy, including pivotal studies leading to FDA approval. He has published several articles in high impact factor journals such as NEJM, Journal of Clinical Oncology, Blood, Nature Medicine, Blood Advances among others. He has alos participated with oral presentations at major meetings such as ASH and ASCO.